Evidence map›Paper›PMID 32219363›Full record

ReviewJAMA cardiology2020

Potential Effects of Coronaviruses on the Cardiovascular System: A Review.

Mohammad Madjid, Payam Safavi-Naeini, Scott D Solomon, Orly Vardeny

7 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in JAMA cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 1,069 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,069citing papers in PubMed, 6 pooled it
43.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04367792 unknown statusnot on this map

Pathology and Pathogenesis of Cardiac Injury in COVID-19 Infections in Humans

TypeobservationalSponsorA.O. Ospedale Papa Giovanni XXIIIRan2020 to 2021Enrolled60ConditionsCOVID-19
NCT04373759 completednot on this map

Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs

Typeobservational_patient_registrySponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur MerRan2020 to 2020Enrolled186ConditionsSars-CoV2, Covid-19ArmsCardiopulmonary resuscitation, Modified Rankin score
NCT04380402 phase2unknown statusnot on this map

Prospective Randomized Open-label Trial of Atorvastatin as Adjunctive Treatment of COVID-19

TypeinterventionalSponsorMount Auburn HospitalRan2020 to 2022Enrolled300ConditionsCOVID-19ArmsAtorvastatin
NCT04475471 unknown statusnot on this map

WHF COVID-19 and Cardiovascular Disease Survey

TypeobservationalSponsorPublic Health Foundation of IndiaRan2020 to 2023Enrolled5,200ConditionsCOVID-19, Cardiovascular Diseases
NCT04513158 phase2terminatednot on this map

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection

TypeinterventionalSponsorJoseph M. Flynn, D.O., MPHRan2020 to 2021Enrolled2ConditionsCovid19ArmsConvalescent Plasma
NCT04869579 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients

TypeinterventionalSponsorCHRISTUS HealthRan2021 to 2021Enrolled100ConditionsCovid19ArmsSelenium (as Selenious Acid), Placebo
NCT05162534 completednot on this map

Evaluation of Independent Clinical- Laboratory Predictors of Clinical Outcomes in Hospitalized Positive SARS-CoV2 Patients (Outcomes SARS-CoV2)

TypeobservationalSponsorUniversity Hospital of FerraraRan2020 to 2021Enrolled1,800ConditionsCOVID-19 PatientsArmseffect of COVID-19 exposure
3 · Its place in the literature

Who cites it

1,069 citing papers in PubMed, 6 syntheses or guidelines pooled it, 1,857 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

1,009 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mohammad MadjidMcGovern Medical School, Department of Medicine, University of Texas Health Science Center at Houston, Houston.
Payam Safavi-NaeiniTexas Heart Institute, Houston.
Scott D SolomonBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Orly VardenyUniversity of Minnesota, Minneapolis.
Harvard University · USThe University of Texas Health Science Center at Houston · USUniversity of Minnesota System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system. Observations: Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications. A large proportion of patients have underlying cardiovascular disease and/or cardiac risk factors. Factors associated with mortality include male sex, advanced age, and presence of comorbidities including hypertension, diabetes mellitus, cardiovascular diseases, and cerebrovascular diseases. Acute cardiac injury determined by elevated high-sensitivity troponin levels is commonly observed in severe cases and is strongly associated with mortality. Acute respiratory distress syndrome is also strongly associated with mortality. Conclusions and Relevance: Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias. Extensive efforts are underway to find specific vaccines and antivirals against SARS-CoV-2. Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines.

Indexed as

BetacoronavirusCardiovascular DiseasesCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2

Identifiers

PMID32219363
OpenAlexW3013949914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.